Smart Medical Devices: Global Markets

Report Highlights

The global market for smart medical devices reached $56.4 billion in 2021 and should reach more than $122.8 billion in 2026, with a compound annual growth rate (CAGR) of 16.8% during the forecast period of 2021-2026.

Report Includes

• 14 data tables and 14 additional tables
• An updated overview of the global market for smart medical devices within the industry
• Analyses of the global market trends, with historic market revenue (sales data) for 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
• Highlights of the current and future market potential for smart medical devices, and areas of focus to forecast this market into various segments and sub-segments
• Evaluation and forecast the global market size for smart medical devices, projected growth trends, and corresponding market share analysis by product type, application, and geographic region
• Technology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2021 to 2026)
• Analysis of market opportunities with detailed Porter’s five forces analysis for the smart medical devices market
• In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• Company profiles of major players within the industry, including Abbott, Boston Scientific Corp., F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Medtronic and Novo Nordisk

Report Scope

This report will provide detailed exposure to the smart medical devices market, analyzing the market trends with data from 2020, estimates from 2021, projections of compound annual growth rates through 2026 (forecast period 2021-2026), and regional markets. The report highlights smart medical devices’ current and future market potential and offers a detailed analysis of the competitive environment, covering regulatory scenarios, drivers, restraints, and opportunities. The report also
covers market projections for 2026 and market share for key market players.

The market has been segmented based on product type, application, and geography. Based on product type, the market in this report is segmented into wearable, non-wearable, and implantable medical devices. The applications of smart medical devices considered in this report include cardiovascular, diabetes, neurology, sleep disorders, and others.

The regional market analysis of smart medical devices is also covered in this report. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, and the Rest of the World (RoW) regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2020 because of the base year, with estimates for 2021 and forecast value for 2026.

*Note: The report’s scope includes smart devices that are medically accepted and approved in the market and excludes smart trackers such as smart watches, wristband sensors, eye-wearing smart glasses, smart belts, earrings, earphones, headphones, gloves, shoes, baseball caps, bras, arm bands, scarfs, and many others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Alzheimer's Disease Therapeutics and Diagnostics: Global Markets (PHM062E)
• Impact Modifiers: Global Markets (AVM252A)
• Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets (CHM073E)
• Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
• Metal-organic Frameworks: Global Markets (AVM200B)